Cargando…

Small-molecule MDM2 antagonists attenuate the senescence-associated secretory phenotype

Processes that have been linked to aging and cancer include an inflammatory milieu driven by senescent cells. Senescent cells lose the ability to divide, essentially irreversibly, and secrete numerous proteases, cytokines and growth factors, termed the senescence-associated secretory phenotype (SASP...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wiley, Christopher D., Schaum, Nicholas, Alimirah, Fatouma, Lopez-Dominguez, Jose Alberto, Orjalo, Arturo V., Scott, Gary, Desprez, Pierre-Yves, Benz, Christopher, Davalos, Albert R., Campisi, Judith
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5799282/ https://www.ncbi.nlm.nih.gov/pubmed/29402901 http://dx.doi.org/10.1038/s41598-018-20000-4

Ejemplares similares

Context-dependent effects of cellular senescence in cancer development
por: Lecot, Pacome, et al.
Publicado: (2016)

Astrocyte senescence promotes glutamate toxicity in cortical neurons
por: Limbad, Chandani, et al.
Publicado: (2020)

Oncogenic senescence: a multi-functional perspective
por: Baker, Darren J., et al.
Publicado: (2017)

Quantitative Proteomic Analysis of the Senescence‐Associated Secretory Phenotype by Data‐Independent Acquisition
por: Neri, Francesco, et al.
Publicado: (2021)

Senescent cells as a source of inflammatory factors for tumor progression
por: Davalos, Albert R., et al.
Publicado: (2010)

SILAC Analysis Reveals Increased Secretion of Hemostasis-Related Factors by Senescent Cells
por: Wiley, Christopher D., et al.
Publicado: (2019)

Antiretroviral protease inhibitors induce features of cellular senescence that are reversible upon drug removal
por: Kuehnemann, Chisaka, et al.
Publicado: (2022)

Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor
por: Coppé, Jean-Philippe, et al.
Publicado: (2008)

A Human-Like Senescence-Associated Secretory Phenotype Is Conserved in Mouse Cells Dependent on Physiological Oxygen
por: Coppé, Jean-Philippe, et al.
Publicado: (2010)

Cell Autonomous and Non-autonomous Effects of Senescent Cells in the Skin
por: Demaria, Marco, et al.
Publicado: (2015)

Deficiency in the DNA repair protein ERCC1 triggers a link between senescence and apoptosis in human fibroblasts and mouse skin
por: Kim, Dong Eun, et al.
Publicado: (2019)

Role of immune cells in the removal of deleterious senescent cells
por: Kale, Abhijit, et al.
Publicado: (2020)

Simvastatin suppresses breast cancer cell proliferation induced by senescent cells
por: Liu, Su, et al.
Publicado: (2015)

MicroRNAs miR-146a/b negatively modulate the senescence-associated inflammatory mediators IL-6 and IL-8
por: Bhaumik, Dipa, et al.
Publicado: (2009)

p53-dependent release of Alarmin HMGB1 is a central mediator of senescent phenotypes
por: Davalos, Albert R., et al.
Publicado: (2013)

Extracellular Nicotinamide Phosphoribosyltransferase Is a Component of the Senescence-Associated Secretory Phenotype
por: Kuehnemann, Chisaka, et al.
Publicado: (2022)

Gene expression signatures of human senescent corneal and conjunctival epithelial cells
por: Kitazawa, Koji, et al.
Publicado: (2023)

Cdkn1a transcript variant 2 is a marker of aging and cellular senescence
por: López-Domínguez, José Alberto, et al.
Publicado: (2021)

Functional Significance of Vitamin D Receptor FokI Polymorphism in Human Breast Cancer Cells
por: Alimirah, Fatouma, et al.
Publicado: (2011)

Senescence and Senolytics: State of the Art on Cellular Senescence, Senolytics, and Healthspan
por: Campisi, Judith
Publicado: (2020)

Reduced transcriptional activity in the p53 pathway of senescent cells revealed by the MDM2 antagonist nutlin-3
por: Huang, Baoying, et al.
Publicado: (2009)

Cellular Senescence, Aging and Cancer
por: Campisi, Judith
Publicado: (2001)

Cellular Senescence and Mammalian Healthspan
por: Campisi, Judith
Publicado: (2020)

Cell senescence, the senescence-associated secretory phenotype, and cancers
por: Langhi Prata, Larissa G. P., et al.
Publicado: (2023)

Preclinical evaluation of the first intravenous small molecule MDM2 antagonist alone and in combination with temozolomide in neuroblastoma
por: Chen, Lindi, et al.
Publicado: (2019)

Interferon-Inducible IFI16, a Negative Regulator of Cell Growth, Down-Regulates Expression of Human Telomerase Reverse Transcriptase (hTERT) Gene
por: Song, Lynda Li, et al.
Publicado: (2010)

Four faces of cellular senescence
por: Rodier, Francis, et al.
Publicado: (2011)

MLL1 is essential for the senescence-associated secretory phenotype
por: Capell, Brian C., et al.
Publicado: (2016)

Structure of a Stapled Peptide Antagonist Bound to Nutlin-Resistant Mdm2
por: Chee, Sharon Min Qi, et al.
Publicado: (2014)

Ceria Nanoparticles Alleviated Osteoarthritis through Attenuating Senescence and Senescence-Associated Secretory Phenotype in Synoviocytes
por: Ren, Xunshan, et al.
Publicado: (2023)

Analysis of individual cells identifies cell‐to‐cell variability following induction of cellular senescence
por: Wiley, Christopher D., et al.
Publicado: (2017)

Mitochondrial DNA damage induces apoptosis in senescent cells
por: Laberge, R-M, et al.
Publicado: (2013)

Cellular senescence, senescence-associated secretory phenotype, and chronic kidney disease
por: Wang, Wen-Juan, et al.
Publicado: (2017)

Persistent DNA damage signaling triggers senescence-associated inflammatory cytokine secretion
por: Rodier, Francis, et al.
Publicado: (2009)

MDM2 Antagonists Counteract Drug-Induced DNA Damage
por: Vilgelm, Anna E., et al.
Publicado: (2017)

Immunotherapeutic approach to reduce senescent cells and alleviate senescence‐associated secretory phenotype in mice
por: Shrestha, Niraj, et al.
Publicado: (2023)

Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype
por: Kumari, Ruchi, et al.
Publicado: (2021)

Deguelin Action Involves c-Met and EGFR Signaling Pathways in Triple Negative Breast Cancer Cells
por: Mehta, Rajeshwari, et al.
Publicado: (2013)

Isolation methodology is essential to the evaluation of the extracellular vesicle component of the senescence‐associated secretory phenotype
por: Wallis, Ryan, et al.
Publicado: (2021)

The Role of Senescence-Associated Secretory Phenotype in Bone Loss
por: Zhu, Runjiu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ob3egmuvotfk3k4uhe1rhijsgb